Cleveland Clinic and Mount Sinai won’t administer Aduhelm; CDC advisory panel to consider vaccine booster shot for immunocompromised patients; Shape Therapeutics raises $112 million for RNA editing.
Five things for health marketers to know: Thursday, July 15, 2021
Olivia Rodrigo partners with Biden administration to boost vaccine confidence; Some private health insurers refuse to cover Aduhelm; Eli Lilly snatches up Protomer Technologies.
Five things for health marketers to know: Wednesday, July 14, 2021
COVID-19 cases rise in areas with low vaccination rates; FDA expresses concerns over FibroGen’s roxadustat; Related Cos. partners with CareMax to develop senior health centers in low-income communities.
Five things for health marketers to know: Tuesday, July 13, 2021
FDA to place new warning on J&J vaccine; Generic Zantac maker won’t face lawsuits over cancer link; Novo Nordisk spends $100 million on Prothena’s ATTR amyloidosis pipeline.
Five things for health marketers to know: Monday, July 12, 2021
Biden administration to aim for drug pricing plan by end of August; Africa faces large surge in COVID-19 cases; Philip Morris plans pivot toward inhaled therapeutics.
Five things for health marketers to know: Friday, July 9, 2021
Most COVID-19 deaths and hospitalizations in U.S. among unvaccinated people; Biogen to narrow Aduhelm’s label; 15 states reach agreement with Purdue on opioids.
Five things for health marketers to know: Thursday, July 8, 2021
COVID-19 cases on the rise in the U.K. due to Delta variant; Moderna begins Phase I/II study to test seasonal flu vaccine; Dollar General hires chief medical officer in effort to expand into healthcare.
Five things for health marketers to know: Wednesday, July 7, 2021
Biden to expand vaccination access to doctor’s offices and work settings; Eli Lilly and Boehringer Ingelheim’s Jardiance passes primary endpoint in trial; Juul battles to keep products on market with FDA application.
Five things for health marketers to know: Tuesday, July 6, 2021
Johnson & Johnson vaccine effective against Delta variant; researchers develop battery-free pacemaker that can be broken down by body; GlaxoSmithKline partners with Alector for neurodegenerative disease antibodies.
Five things for health marketers to know: Friday, July 2, 2021
U.S. unlikely to reach vaccination goal by Independence Day; Seres Therapeutics makes $175 million deal with Nestlé Health Science over microbiome drug; Biden administration prepares for next pandemic.